AVAI
Atlas Venture Associates IX Portfolio holdings
AUM
$11.8M
This Quarter Return
+12.87%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
–
AUM
$568M
AUM Growth
+$568M
(-4.5%)
Cap. Flow
-$180M
Cap. Flow
% of AUM
-31.61%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Intellia Therapeutics
NTLA
|
$179M |
| 2 |
Skillz
SKLZ
|
$1.15M |
Sector Composition
| 1 | Communication Services | 89.34% |
| 2 | Healthcare | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Skillz
SKLZ
$135M
| $498M | 87.54% |
22,909,859
-53,051
| -0.2% | -$1.15M |
|
|
SURF
2
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $22M | 3.87% |
2,945,453
| – | – |
|
3
Spero Therapeutics
SPRO
$116M
| $19.2M | 3.38% |
1,376,968
| – | – |
|
4
Synlogic
SYBX
$17M
| $10.3M | 1.82% |
2,651,963
| – | – |
|
5
Snap
SNAP
$12.1B
| $10.2M | 1.8% |
150,160
| – | – |
|
6
Cogent Biosciences
COGT
$1.69B
| $7.44M | 1.31% |
916,832
| – | – |
|
|
7
Intellia Therapeutics
NTLA
$1.22B
| $1.62M | 0.28% |
10,000
-1,103,376
| -99% | -$179M |
|